Wireless ECG System

The system has been cleared by the U.S. Food and Drug Administration (FDA).

Called LifeSync, the system was evaluated in about 400 patients in different departments of three hospitals: the cardic care unit (CCU), intensive care unit (ICU), cardiac stress and cardiac catheterization laboratories, and the admission and recovery units for pre- and post-cardiac catheterization procedures. ECG monitoring using the system compared favorably with traditional wired ECG monitoring.

The system is the first to eliminate lead wires and trunk cables between patients and bedside. Standard ECG electrodes are attached to the disposable LeadWear system worn by the patient. Two-way radios transmit and receive patient ECG and respiration data to existing ECG monitors. LifeSync is designed to save critical nurse time by eliminating the need to detach and re-attach lead wires when transporting patients, and it also facilitates patient mobility and ambulation. The system was developed by GMP Companies, Inc. (Fort Lauderdale, FL, USA).

"LifeSync's advantages include enhanced patient comfort, easier patient transport and mobility, and most importantly, potential to reduce the risk of cross contamination from traditional lead wires,” noted Dr. Michael Seneff, director, critical care medicine, George Washington University Hospital (Washington, DC, USA), one of the hospitals involved in the evaluation.




Related Links:
GMP